Background Racial and ethnic disparities in infectious disease burden have been reported in the USA and globally, most recently during the COVID-19 pandemic. It remains unclear whether such ...

Trends and spatial patterns of human immunodeficiency virus prevalence among men and women aged 15–49 in Sierra Leone: evidence from the 2008, 2013 and 2019 Demographic and Health Surveys (5 August, ...

Introduction Burden of non-communicable diseases (NCDs) continues to rise in low- and middle-income countries like Kenya. People with HIV (PWH) may be at greater risk for obesity and NCDs. National ...

Setting health systems research priorities for Afghanistan: an application of the child health and nutrition research initiative (CHNRI) methodology to set a roadmap to 2030 (25 July, 2025 ...

Introduction Hypertensive disorders of pregnancy (HDP) have been linked with increased risk for maternal and offspring complications in high-income settings. However, in resource-limited settings, ...

We sought to assess the feasibility of mainstreaming balanced energy protein supplementation, a maternal nutrition intervention, into Bangladesh’s routine antenatal care system in tandem with an ...

High-burden cholera outbreaks, spreading beyond the traditional cholera-endemic countries, have been reported since 2021 in the WHO African region. Member states in the region have committed to the ...

Background The prevalence of hypertension (HTN) is increasing among people with HIV (PHIV) across sub-Saharan Africa. However, little data exist on the effectiveness of integrated HIV and HTN care ...

COVID-19 has posed an unprecedented global health crisis, demanding timely, reliable information on the pandemic’s progression to inform the public and guide decision-making. The WHO’s COVID-19 Weekly ...

Background Lassa fever (LF) is a severe re-emerging infectious disease caused by the Lassa virus (LV). LF is a priority disease on the World Health Organization’s R&D blueprint and affects a large ...

Background HIV drug resistance (HIVDR) remains a major threat to achieving sustainable viral suppression on antiretroviral therapy (ART). In South Africa, dolutegravir (DTG) is the preferred ...

Background Rapid detection of resistance to key drugs such as fluoroquinolones (FQ) and bedaquiline (BDQ) is essential for appropriate management of multi-drug resistant tuberculosis (MDR-TB). .